Detalhe da pesquisa
1.
Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programme.
Intern Med J
; 2024 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369719
2.
Dendritic cells as cancer therapeutics.
Semin Cell Dev Biol
; 86: 77-88, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29454038
3.
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
Lancet Oncol
; 18(9): 1202-1210, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729151
4.
Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.
J Am Acad Dermatol
; 74(3): 455-61.e1, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26793994
5.
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
Nature
; 464(7291): 1071-6, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20393566
6.
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study.
Front Oncol
; 14: 1305720, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406805
7.
RNA-Seq mapping and detection of gene fusions with a suffix array algorithm.
PLoS Comput Biol
; 8(4): e1002464, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22496636
8.
Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis.
Biomedicines
; 11(7)2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509467
9.
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.
BMJ Support Palliat Care
; 13(3): 354-362, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807048
10.
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience.
Front Oncol
; 13: 1154246, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37124503
11.
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Neurooncol Adv
; 5(1): vdad124, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841696
12.
Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture.
J Infect Dis
; 203(12): 1753-62, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21606534
13.
Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspective.
Asia Pac J Clin Oncol
; 18(3): 259-266, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166569
14.
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.
BMJ Open
; 12(9): e058107, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104135
15.
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and Researchers.
Curr Oncol
; 29(12): 9928-9955, 2022 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36547195
16.
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Cancers (Basel)
; 13(19)2021 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638308
17.
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study.
BMJ Open
; 11(12): e054075, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185327
18.
Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics.
J Leukoc Biol
; 107(2): 323-339, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31749181
19.
On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy.
Front Oncol
; 9: 50, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30788290
20.
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission.
Oncoimmunology
; 7(4): e1419114, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632738